Welcome to LookChem.com Sign In|Join Free
  • or
S-Ethyl-L-cysteine is a naturally occurring compound found in various foods, particularly those from the allium family such as garlic and onions. It is a derivative of the amino acid L-cysteine, known for its potential health benefits, including antioxidant properties and protective effects against certain types of cancer. S-Ethyl-L-cysteine also has potential in reducing the toxic effects of alcohol, protecting against liver damage, lowering cholesterol levels, and improving cardiovascular health. It is a promising compound with various potential health benefits and is a subject of ongoing research and study.

2629-59-6

Post Buying Request

2629-59-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2629-59-6 Usage

Uses

Used in Antioxidant Applications:
S-Ethyl-L-cysteine is used as an antioxidant agent for its potential to neutralize harmful free radicals and protect cells from oxidative damage, contributing to overall health and well-being.
Used in Cancer Prevention:
S-Ethyl-L-cysteine is used as a chemopreventive agent for its potential protective effects against certain types of cancer, possibly through its antioxidant properties and other mechanisms that are still under investigation.
Used in Liver Protection:
S-Ethyl-L-cysteine is used as a hepatoprotective agent for its potential to reduce the toxic effects of alcohol and protect against liver damage, supporting liver health and function.
Used in Cardiovascular Health:
S-Ethyl-L-cysteine is used as a cardiovascular health promoter for its potential to lower cholesterol levels and improve cardiovascular health, reducing the risk of heart diseases.
Used in Pharmaceutical Industry:
S-Ethyl-L-cysteine is used as a pharmaceutical compound for its potential therapeutic applications in various health conditions, including cancer prevention, liver protection, and cardiovascular health improvement.
Used in Nutraceutical Industry:
S-Ethyl-L-cysteine is used as a nutraceutical ingredient for its potential health benefits, which can be incorporated into dietary supplements and functional foods to support overall health and well-being.

Check Digit Verification of cas no

The CAS Registry Mumber 2629-59-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,2 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2629-59:
(6*2)+(5*6)+(4*2)+(3*9)+(2*5)+(1*9)=96
96 % 10 = 6
So 2629-59-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO2S/c1-2-6-4(3-9)5(7)8/h4,6,9H,2-3H2,1H3,(H,7,8)/t4-/m0/s1

2629-59-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name S-ETHYL-L-CYSTEINE

1.2 Other means of identification

Product number -
Other names S-Aethyl-L-cystein

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2629-59-6 SDS

2629-59-6Relevant academic research and scientific papers

Influence of Sulfoxide Group Placement on Polypeptide Conformational Stability

Gharakhanian, Eric G.,Bahrun, Ehab,Deming, Timothy J.

supporting information, p. 14530 - 14533 (2019/10/02)

The synthesis of a homologous series containing five new nonionic sulfoxide containing polypeptides was described. Sulfoxide groups bestowed water solubility for all homologues, which allowed their use as a model for study of helix-coil transitions in water while avoiding contributions from charged groups or phase separation. Polypeptides were found to adopt chain conformations in water that were dependent on distance of sulfoxides from chain backbones, overall side-chain lengths, and solvent. These results allow preparation of polypeptide segments with different chain conformations without changing chemical functionality for potential use in structural studies and functional applications.

Derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, preparation method and use thereof

-

Paragraph 0111-0112, (2019/01/08)

The invention relates to a derivative of Kutkin dimer analog JJA-D0 or its pharmaceutically acceptable salt, a preparation method and use thereof. The compound has a structure shown as a general formula (I). According to the invention, an alkyl group, an aryl group, a heteroaryl group, an alkoxycarbonylalkyl group, an acyl group, a sulfonate group, an antioxidant group such as a lipoic acid group,a H2S donor group such as a cysteine group, and a NO donor group such as a nitrate group are introduced to JJA-D0, and a series of structurally novel compounds can be synthesized and disclosed. The compounds inhibit NADPH oxidase and have superior anti-oxidation and anti-inflammatory pharmacological mechanisms by comparing with Kutkin, the compounds also have donor groups that provide NO and H2S,can further enhance pharmacological activity, and can be a new class of multifunctional compounds. The disclosed JJA-D0 derivative can be used for preparing health products or drugs for prevention ortreatment of diseases associated with NADPH oxidase, diseases associated with free radicals, diseases associated with inflammation, diseases associated with NO, and diseases associated with H2S.

A step-by-step crystallization for preparing thio alkyl/alkenyl cysteine sulfoxide method

-

Paragraph 0065; 0066, (2017/05/26)

The invention discloses a method for preparing thioalkyl/alkenyl cysteine sulfoxide by fractional crystallization, belonging to the technical field of compound preparation. The method comprises the following steps: adding cysteine or cysteine salts, a sodium hydroxide solution and an R group (alkyl or alkenyl)-derived material into absolute ethanol in sequence for reaction to synthesize coarse ACSs, re-crystallizing ACSs, purifying, oxidizing to form ACSOs, and fractionally crystallizing to obtain natural dextrorotatory ACSOs, wherein the R group-derived material is replaced to synthesize different types of ACSOs in allium; enantiomers in racemes are separated by adopting the fractional crystallization method to obtain natural dextrorotatory ACSOs with optical activity. Compared with a conventional extraction method, the method has the characteristics that the yield and the purity are high, a conventional complicated extraction process is avoided, the product has the optical activity, and the physical property is close to that of natural extract; the product is used in the fields of health products, pharmaceuticals and the like, the effects of resisting bacteria and cancers, reducing blood fat and the like of ACSOs are brought into play, or the product serves as an intermediate such as an active ingredient-diallyl thiosulfinate for synthesizing allium.

Efficient S-alkylation of cysteine in the presence of 1,1,3,3- tetramethylguanidine

W?ostowski, Marek,Czarnocka, Sylwia,MacIejewski, Piotr

experimental part, p. 5977 - 5979 (2010/11/21)

The synthesis of S-alkylated cysteine derivatives was carried out successfully in the presence of 1,1,3,3-tetramethylguanidine. Alkylation proceeded in high yields on unprotected amino acids and peptides containing a sulfhydryl group.

Method Of Synthesizing S-Allyl-Cysteine Analogues And Their Therapeutic Application In Treating Myocardial Infarction

-

Page/Page column 9; 10, (2009/04/24)

A pharmaceutical composition and methods of producing and application of the composition for treating myocardial infarction of a subject are disclosed. The pharmaceutical composition comprises a therapeutically effective amount of at least one synthesized compound selected from the group consisting of SEC, SPC, SBC, SPEC, SAC, SAMC, and SPRC, and a pharmaceutically acceptable carrier.

Cysteine based novel noncompetitive inhibitors of urease(s)-Distinctive inhibition susceptibility of microbial and plant ureases

Amtul, Zareen,Kausar, Naheed,Follmer, Cristian,Rozmahel, Richard F.,Atta-Ur-Rahman,Kazmi, Syed Arif,Shekhani, Mohammed Saleh,Eriksen, Jason L.,Khan, Khalid M.,Choudhary, Mohammad Iqbal

, p. 6737 - 6744 (2007/10/03)

Based on the catalysis mechanism of urease, a homologous series of 10 cysteine derivatives (CysDs) was designed and synthesized, and their inhibitory activities were evaluated for microbial ureases (Bacillus pasteurii, BPU, and Proteus mirabilis, PMU) and for a plant urease [jack bean (Cavavalia ensiformis), JBU]. As already described, thiol-compounds might inhibit urease activity by chelating the nickel atoms involved in the catalysis process. In contrast to cysteine, which has been reported to be a very weak urease inhibitor, we verified a potential inhibitory activity of these CysDs. The kinetic data demonstrate that thiol derivatives are more effective than the respective thioether derivatives. Besides, thiol-CysDs had a reduced activity in acidic pH (5.0). Lineweaver-Burk plots indicated that the nature of inhibition was of noncompetitive type for all 10 compounds, with the minimum Ki value of 2 μM for N,N-dimethyl l-cysteine. It is proposed that these classes of compounds are more potent inhibitors of the bacterial ureases, compared with the plant-originated urease. Since microbial urease is directly involved in the infection process of many pathological organisms, this work demonstrates that thiol-CysDs represent a class of new potential urease inhibitors.

Acylase I-catalyzed deacetylation of N-acetyl-L-cysteine and S-alkyl-N- acetyl-L-cysteines

Uttamsing, Vinita,Keller,Anders

, p. 800 - 809 (2007/10/03)

The aminoacylase that catalyzes the hydrolysis of N-acetyl-L-cysteine (NAC) was identified as acylase I after purification by column chromatography and electrophoretic analysis. Rat kidney cytosol was fractionated by ammonium sulfate precipitation, and the proteins were separated by ion-exchange column chromatography, gel-filtration column chromatography, and hydrophobic interaction column chromatography. Acylase activity with NAC and N-acetyl-L- methionine (NAM), a known substrate for acylase I, as substrates coeluted during all chromatographic steps. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that the protein was purified to near homogeneity and had a subunit M(r) of 43 000, which is identical with the M(r) of acylase I from porcine kidney and bovine liver. n-Butylmalonic acid was a slow-binding inhibitor of acylase I and inhibited the deacetylation of NAC with a K(i) of 192 ± 27 μM. These results show that acylase I catalyzes the deacetylation of NAC. The acylase I-catalyzed deacetylation of a range of S-alkyl-N- acetyl-L-cysteines, their carbon and oxygen analogues, and the selenium analogue of NAM was also studied with porcine kidney acylase I. The specific activity of the acylase I-catalyzed deacetylation of these substrates was related to their calculated molar volumes and log P values. The S-alkyl-N- acetyl-L-cysteines with short (C0-C3) and unbranched S-alkyl substituents were good acylase I substrates, whereas the S-alkyl-N-acetyl-L-cysteines with long (>C3) and branched S-alkyl substituents were poor acylase I substrates. The carbon and oxygen analogues of S-methyl-N-acetyl-L-cysteine and the carbon analogue of S-ethyl-N-acetyl-L-cysteine were poor acylase I substrates, whereas the selenium analogue of NAM was a good acylase I substrate.

Enzymatic Synthesis of S-Substituted L-Cysteines with Tryptophan Synthase of Escherichia coli

Esaki, Nobuyoshi,Tanaka, Hidehiko,Miles, Edith Wilson,Soda, Kenji

, p. 2861 - 2864 (2007/10/02)

The α2β2 comlex of tryptophan syntase from Escherichia coli catalyzes β-replacement reactions of L-serine and its derivatives (e.g., β-chloro-L-alanine and O-methyl-DL-serine) with various alkanethiols.The products from thiobenzyl alcohol and ethanethiol were isolated to demonstrate the enzymatic synthesis of the corresponding S-substituted L-cysteines.Reactivities of various S-substituent donors were examined, and thiols such as thiobenzyl alcohol, 1-propanethiol and 1-butanethiol were found to be much more efficient substituent donors than the physiological substrate, indole.In addition, tryptophan synthase catalyzes β-replacement reactions of L-threonine with thiols to form the corresponding S-substituted β-methylcysteines, which are also produced by β-addition reactions of L-vinylglycine with thiols.These enzymatic reactions facilitate the synthesis of various sulfur-containing amino acids.

Synthesis of L-Cysteine and Its Analogues by Intact Cells Containing Cysteine Desulfhydrase

Ohkishi, Haruyuki,Nishikawa, Daikichiro,Kumagai, Hidehiko,Yamada, Hideaki

, p. 259 - 264 (2007/10/02)

Cysteine desulfhydrase catalyzes β-replacement, the reverse reaction of α,β-elimination, as well as α,β-elimination.These reactions were studied with intact cells of Aerobacter aerogenes I-3-2 and Aerobacter cloacae IFO 12009 containing cysteine desulfhydrase.L-Cysteine and its analogues were synthesized by replacement and reverse reactions using intact cells. β-Chloro-L-alanine, L-cysteine, S-methyl-L-cysteine, S-allyl-L-cysteine and L-serine were used as substrates together with hydrogen sulfide and methyl mercaptan to synthesize L-cysteine and S-methyl-L-cysteine via replacement reaction by intact cells.L-Cysteine synthesized from β-chloro-L-alanine was confirmed to be entirely in L-form after isolation and identification of the product.The reverse reaction for synthesis of L-cysteine and S-methyl-L-cysteine from hydrogen sulfide or methyl mercaptan, pyruvate and ammonia was also catalyzed by intact cells. β-Chloro-L-alanine was found to be the best substrate for synthesis of L-cysteine and S-methyl-L-cysteine by β-replacement reaction.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2629-59-6